Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Recent clinical trials summary.

Daniel R Nathanson1, Charles R Thomas, Ronald Bleday

  • 1Department of Surgery, Brigham and Women's Hospital, 75 Francis Street, Boston, MA 02115, USA.

Surgical Oncology Clinics of North America
|May 13, 2004
PubMed
Summary

The standard treatment for anal cancer combines 5-fluorouracil (5-FU) and mitomycin C with radiation therapy. Ongoing research aims to refine this approach and explore the roles of human papillomavirus (HPV) and dysplasia.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Sequencing Paradox of Immunotherapy and Thoracic Radiotherapy.

JAMA oncology·2026
Same author

Impact of vitamin D on the colon cancer immune microenvironment: results of a randomized clinical trial of preoperative vitamin D supplementation in patients with stage I-III colon cancer.

Cancer discovery·2026
Same author

Quadratus Lumborum Block During Minimally Invasive Colorectal Surgery: A Tool for Enhanced Recovery.

Diseases of the colon and rectum·2026
Same author

Automatic Tenure-Clock Extensions as a Safeguard Against Defunding.

Annals of internal medicine·2026
Same author

Lymph Node Harvest and Survival Among Patients With Locally Advanced Appendiceal Adenocarcinoma.

The Journal of surgical research·2026
Same author

Performance of Stereotactic Radiotherapy vs Hippocampal-Avoidance Whole Brain Radiation.

JAMA oncology·2026

Area of Science:

  • Oncology
  • Radiation Oncology
  • Medical Oncology

Background:

  • The established treatment for anal cancer involves chemoradiation.
  • The combination of 5-fluorouracil (5-FU) and mitomycin C (MMC) with radiation therapy has been the standard for decades.
  • Nigro's approach remains the cornerstone of anal cancer treatment protocols.

Purpose of the Study:

  • To summarize the current standard of care for anal cancer treatment.
  • To highlight the long-standing efficacy of 5-FU and mitomycin C combined with radiation.
  • To identify future research directions, including the role of human papillomavirus (HPV) and dysplasia.

Main Methods:

  • Review of completed phase 3 clinical trials in anal cancer treatment.
  • Analysis of the historical development and current application of the Nigro protocol.
  • Identification of key areas for future clinical investigation.

Main Results:

  • The combination of 5-FU and mitomycin C with radiation therapy is the current standard of care.
  • The fundamental treatment strategy has remained consistent for over 30 years.
  • Future trials are expected to refine this standard and investigate etiological factors.

Conclusions:

  • The current chemoradiation regimen is a well-established and effective treatment for anal cancer.
  • Further research is necessary to optimize treatment and understand the contribution of HPV and dysplasia to anal cancer.
  • The field is poised for advancements in understanding the disease's development and progression.

Related Experiment Videos